I suspect the issue may be, that MSB sees mileage in impressing regulators with multiple PhII trials, across multiple disease types [ie, diabetes and RA]......and aiming for lumping all that data in and saying....."can we get some type of breakthrough/early approval please".
I'm not sure the FDA approves things on the basis of, "They are not just trying one thing; they are trying lots of things, so yeah, in that case we'll give them the green light."
"but I think RA is just about complete with its PhII now and D is done....so a decision point has been arrived at. "
I'm not sure what you mean by "D is done".
Because if it was, a decision would not take so long to make.
It's going on for 10 months since they published Phase2 trial results.
That would be long enough a time period over which to negotiate and conclude a partnership, so they must be close to announcing one, other wise as you said, it would be a pity if they dropped the ball on this one...
- Forums
- ASX - By Stock
- MSB
- Diabetes.......where are we at?
Diabetes.......where are we at?, page-8
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
98.0¢ |
Change
0.010(1.03%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
96.0¢ | 99.0¢ | 95.5¢ | $5.286M | 5.409M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 91218 | 98.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 63577 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 91218 | 0.980 |
42 | 307626 | 0.975 |
14 | 519246 | 0.970 |
6 | 149303 | 0.965 |
8 | 166210 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 63577 | 4 |
0.995 | 68052 | 2 |
1.000 | 121535 | 11 |
1.005 | 55374 | 2 |
1.010 | 10000 | 1 |
Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |